Αποτελέσματα Αναζήτησης
18 Νοε 2024 · The MDL or other Zantac class actions are not guaranteed to use a tier system. But if the courts decide to implement one, the anticipated settlement tiers may be: Tier I injuries: Stomach, breast, pancreatic or prostate cancer with payouts from $300,000 to $500,000
9 Οκτ 2024 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
1 Νοε 2024 · The main claim in Zantac lawsuits was that defendants failed to warn the public adequately that Zantac’s active ingredient, ranitidine, is unstable and can form NDMA in the stomach, which in turn leads to an increased risk of cancer.
22 Νοε 2024 · Today, the federal judge overseeing the Zantac class action lawsuit has dismissed every Zantac claim in the MDL. In a lengthy Order , the court ruled that the Plaintiffs failed to meet their scientific burden of proof showing that the NDMA in Zantac increased the risk of developing cancer.
14 Οκτ 2024 · GSK agreed to pay as much as $2.2 billion to put an end to the majority of complaints arguing the now-discontinued Zantac heartburn medication the British drugmaker manufactured and sold caused cancer. The Zantac settlement resolved around 80,000 cases filed against GSK in a number of different U.S. state courts, Reuters reports.
4 ημέρες πριν · GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer.
10 Οκτ 2024 · Calculating Zantac (ranitidine) settlement amounts & potential payouts starts with understanding how damages work. Learn how much your Zantac case may be worth.
